Hikurangi Bioactives Limited Partnership (HBLP) is a joint venture between Hikurangi Enterprises Limited (HEL), New Zealand Nutraceuticals Limited (NZNL) and Hikurangi Bioactives General Partner Limited.
When HBLP dividends are paid, 60% goes to HEL and 40% to NZNL.
HBLP has invested in a range of biotechnology projects with research organisations in New Zealand. A number of joint projects have been established between HBLP, Māori landowners, private companies and research entities.
HBLP has two directors: Carey Manuel and Damian Skinner.
– – –
Find out more at: www.hikurangibioactives.co.nz